Toggle navigation
Home
Search
Services
Blog
Contact
About
Resorbable Tubular Collagen Implant - Endoscopic Repair
Shu-Tung, Li
Regen Biologics, Inc., Franklin Lakes, NJ, United States
Search 26 grants from Li Shu-Tung
Search grants from Regen Biologics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Hepatoprotective Mechanisms of TTC39B Deficiency
NHGRI/DIR Flow Cytometry Core
Plasmodium carbohydrate receptors in Anopheles gambiae
Gasp - A Software Tool for Methodologic Development in Statistical Genetics
Mitigating antibiotic resistance in drinking water by understanding the impact of corrosion inhibitors and corrosion products
Recently added grants:
Inflammatory microenvironment in brain metastasis
Understanding the Adoption and Impact of New Risk Assessment Technologies in Prostate Cancer Care
Leveraging tumor registries and pathology specimens to facilitate genetic testing and traceback for ovarian cancer
Pro-tumor functions of neutrophils in squamous cell lung cancer
Artificial Intelligence driven prediction of brain metastasis from primary tumor sites at diagnosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43DK052225-001
Application #
2307417
Study Section
Project Start
1995-09-05
Project End
1996-05-30
Budget Start
1996-03-26
Budget End
1996-05-30
Support Year
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Regen Biologics, Inc.
Department
Type
DUNS #
City
Franklin Lakes
State
NJ
Country
United States
Zip Code
07417
Related projects
NIH 1996
N43 DK
Resorbable Tubular Collagen Implant - Endoscopic Repair
Shu-Tung, Li / Regen Biologics, Inc.
NIH 1995
N43 DK
Resorbable Tubular Collagen Implant - Endoscopic Repair
Shu-Tung, Li / Regen Biologics, Inc.
Comments
Be the first to comment on Li Shu-Tung's grant